Selected research
Market Structure
Global Chemical API CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Chemical API CDMO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Chemical API CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Chemical API CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Chemical API CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Chemical API CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Chemical API CDMO include Flamma Group, HAS Healthcare, Asymchem, Recipharm, Pierre Fabre, Pfizer CentreOne, Axplora, Lonza and MAI CDMO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Chemical API CDMO market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Chemical API CDMO and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Chemical API CDMO revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Chemical API CDMO market size, projected growth trends, production technologies, key applications, and end-use industries.
Chemical API CDMO Segment by Company
Flamma Group
HAS Healthcare
Asymchem
Recipharm
Pierre Fabre
Pfizer CentreOne
Axplora
Lonza
MAI CDMO
BioVectra
Curia
AGC Pharma Chemicals
Asymchem
Olon Group
Evonik Health Care
Teva Active Pharmaceutical Ingredients
Chemical API CDMO Segment by Type
Small Molecule CDMO
Macromolecule CDMO
Cell Gene Therapy (CGT) CDMO
Chemical API CDMO Segment by Application
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Hospital
Others
Chemical API CDMO Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chemical API CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chemical API CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chemical API CDMO.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Chemical API CDMO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Chemical API CDMO industry.
Chapter 3: Detailed analysis of Chemical API CDMO companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chemical API CDMOrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Small Molecule CDMO
- Macromolecule CDMO
- Cell Gene Therapy (CGT) CDMO
Applications
- Pharmaceutical and Biotechnology Companies
- Research and Academic Institutions
- Hospital
- Others
Companies covered
- Flamma Group
- HAS Healthcare
- Asymchem
- Recipharm
- Pierre Fabre
- Pfizer CentreOne
- Axplora
- Lonza
- MAI CDMO
- BioVectra
- Curia
- AGC Pharma Chemicals
- Asymchem
- Olon Group
- Evonik Health Care
- Teva Active Pharmaceutical Ingredients
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Chemical API CDMO Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Small Molecule CDMO
- 1.2.3 Macromolecule CDMO
- 1.2.4 Cell Gene Therapy (CGT) CDMO
- 1.3 Market Analysis by Application
- 1.3.1 Global Chemical API CDMO Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical and Biotechnology Companies
- 1.3.3 Research and Academic Institutions
- 1.3.4 Hospital
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Chemical API CDMO Growth Trends by Region
- 1.5.1 Global Chemical API CDMO Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Chemical API CDMO Market Size by Region (2021-2026)
- 1.5.3 Chemical API CDMO Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Chemical API CDMO Market Dynamics
- 2.1 Chemical API CDMO Industry Trends
- 2.2 Chemical API CDMO Industry Drivers
- 2.3 Chemical API CDMO Industry Opportunities and Challenges
- 2.4 Chemical API CDMO Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Chemical API CDMO Revenue by Company (2021-2026)
- 3.2 Global Chemical API CDMO Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Chemical API CDMO Key Company Head office and Area Served
- 3.4 Global Chemical API CDMO Company, Product Type & Application
- 3.5 Global Chemical API CDMO Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Chemical API CDMO Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Chemical API CDMO Players Market Share by Revenue in 2025
- 3.6.3 2025 Chemical API CDMO Tier 1, Tier 2, and Tier 3
4 Chemical API CDMO Market by Type
- 4.1 Global Chemical API CDMO Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Chemical API CDMO Market Size by Type (2021-2032)
- 4.3 Global Chemical API CDMO Market Size Share by Type (2021-2032)
5 Chemical API CDMO Market by Application
- 5.1 Global Chemical API CDMO Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Chemical API CDMO Market Size by Application (2021-2032)
- 5.3 Global Chemical API CDMO Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Flamma Group
- 6.1.1 Flamma Group Company Information
- 6.1.2 Flamma Group Business Overview
- 6.1.3 Flamma Group Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Flamma Group Chemical API CDMO Product Portfolio
- 6.1.5 Flamma Group Recent Developments
- 6.2 HAS Healthcare
- 6.2.1 HAS Healthcare Company Information
- 6.2.2 HAS Healthcare Business Overview
- 6.2.3 HAS Healthcare Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 HAS Healthcare Chemical API CDMO Product Portfolio
- 6.2.5 HAS Healthcare Recent Developments
- 6.3 Asymchem
- 6.3.1 Asymchem Company Information
- 6.3.2 Asymchem Business Overview
- 6.3.3 Asymchem Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Asymchem Chemical API CDMO Product Portfolio
- 6.3.5 Asymchem Recent Developments
- 6.4 Recipharm
- 6.4.1 Recipharm Company Information
- 6.4.2 Recipharm Business Overview
- 6.4.3 Recipharm Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Recipharm Chemical API CDMO Product Portfolio
- 6.4.5 Recipharm Recent Developments
- 6.5 Pierre Fabre
- 6.5.1 Pierre Fabre Company Information
- 6.5.2 Pierre Fabre Business Overview
- 6.5.3 Pierre Fabre Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Pierre Fabre Chemical API CDMO Product Portfolio
- 6.5.5 Pierre Fabre Recent Developments
- 6.6 Pfizer CentreOne
- 6.6.1 Pfizer CentreOne Company Information
- 6.6.2 Pfizer CentreOne Business Overview
- 6.6.3 Pfizer CentreOne Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Pfizer CentreOne Chemical API CDMO Product Portfolio
- 6.6.5 Pfizer CentreOne Recent Developments
- 6.7 Axplora
- 6.7.1 Axplora Company Information
- 6.7.2 Axplora Business Overview
- 6.7.3 Axplora Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Axplora Chemical API CDMO Product Portfolio
- 6.7.5 Axplora Recent Developments
- 6.8 Lonza
- 6.8.1 Lonza Company Information
- 6.8.2 Lonza Business Overview
- 6.8.3 Lonza Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Lonza Chemical API CDMO Product Portfolio
- 6.8.5 Lonza Recent Developments
- 6.9 MAI CDMO
- 6.9.1 MAI CDMO Company Information
- 6.9.2 MAI CDMO Business Overview
- 6.9.3 MAI CDMO Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 MAI CDMO Chemical API CDMO Product Portfolio
- 6.9.5 MAI CDMO Recent Developments
- 6.10 BioVectra
- 6.10.1 BioVectra Company Information
- 6.10.2 BioVectra Business Overview
- 6.10.3 BioVectra Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 BioVectra Chemical API CDMO Product Portfolio
- 6.10.5 BioVectra Recent Developments
- 6.11 Curia
- 6.11.1 Curia Company Information
- 6.11.2 Curia Business Overview
- 6.11.3 Curia Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Curia Chemical API CDMO Product Portfolio
- 6.11.5 Curia Recent Developments
- 6.12 AGC Pharma Chemicals
- 6.12.1 AGC Pharma Chemicals Company Information
- 6.12.2 AGC Pharma Chemicals Business Overview
- 6.12.3 AGC Pharma Chemicals Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 AGC Pharma Chemicals Chemical API CDMO Product Portfolio
- 6.12.5 AGC Pharma Chemicals Recent Developments
- 6.13 Asymchem
- 6.13.1 Asymchem Company Information
- 6.13.2 Asymchem Business Overview
- 6.13.3 Asymchem Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Asymchem Chemical API CDMO Product Portfolio
- 6.13.5 Asymchem Recent Developments
- 6.14 Olon Group
- 6.14.1 Olon Group Company Information
- 6.14.2 Olon Group Business Overview
- 6.14.3 Olon Group Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Olon Group Chemical API CDMO Product Portfolio
- 6.14.5 Olon Group Recent Developments
- 6.15 Evonik Health Care
- 6.15.1 Evonik Health Care Company Information
- 6.15.2 Evonik Health Care Business Overview
- 6.15.3 Evonik Health Care Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Evonik Health Care Chemical API CDMO Product Portfolio
- 6.15.5 Evonik Health Care Recent Developments
- 6.16 Teva Active Pharmaceutical Ingredients
- 6.16.1 Teva Active Pharmaceutical Ingredients Company Information
- 6.16.2 Teva Active Pharmaceutical Ingredients Business Overview
- 6.16.3 Teva Active Pharmaceutical Ingredients Chemical API CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Teva Active Pharmaceutical Ingredients Chemical API CDMO Product Portfolio
- 6.16.5 Teva Active Pharmaceutical Ingredients Recent Developments
7 North America
- 7.1 North America Chemical API CDMO Market Size (2021-2032)
- 7.2 North America Chemical API CDMO Market Size by Type
- 7.2.1 North America Chemical API CDMO Market Size by Type (2021-2026)
- 7.2.2 North America Chemical API CDMO Market Size by Type (2027-2032)
- 7.2.3 North America Chemical API CDMO Market Share by Type (2021-2032)
- 7.3 North America Chemical API CDMO Market Size by Application
- 7.3.1 North America Chemical API CDMO Market Size by Application (2021-2026)
- 7.3.2 North America Chemical API CDMO Market Size by Application (2027-2032)
- 7.3.3 North America Chemical API CDMO Market Share by Application (2021-2032)
- 7.4 North America Chemical API CDMO Market Size by Country
- 7.4.1 North America Chemical API CDMO Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Chemical API CDMO Market Size by Country (2021-2026)
- 7.4.3 North America Chemical API CDMO Market Size by Country (2027-2032)
- 7.4.4 North America Chemical API CDMO Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Chemical API CDMO Market Size (2021-2032)
- 8.2 Europe Chemical API CDMO Market Size by Type
- 8.2.1 Europe Chemical API CDMO Market Size by Type (2021-2026)
- 8.2.2 Europe Chemical API CDMO Market Size by Type (2027-2032)
- 8.2.3 Europe Chemical API CDMO Market Share by Type (2021-2032)
- 8.3 Europe Chemical API CDMO Market Size by Application
- 8.3.1 Europe Chemical API CDMO Market Size by Application (2021-2026)
- 8.3.2 Europe Chemical API CDMO Market Size by Application (2027-2032)
- 8.3.3 Europe Chemical API CDMO Market Share by Application (2021-2032)
- 8.4 Europe Chemical API CDMO Market Size by Country
- 8.4.1 Europe Chemical API CDMO Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Chemical API CDMO Market Size by Country (2021-2026)
- 8.4.3 Europe Chemical API CDMO Market Size by Country (2027-2032)
- 8.4.4 Europe Chemical API CDMO Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Chemical API CDMO Market Size (2021-2032)
- 9.2 China Chemical API CDMO Market Size by Type
- 9.2.1 China Chemical API CDMO Market Size by Type (2021-2026)
- 9.2.2 China Chemical API CDMO Market Size by Type (2027-2032)
- 9.2.3 China Chemical API CDMO Market Share by Type (2021-2032)
- 9.3 China Chemical API CDMO Market Size by Application
- 9.3.1 China Chemical API CDMO Market Size by Application (2021-2026)
- 9.3.2 China Chemical API CDMO Market Size by Application (2027-2032)
- 9.3.3 China Chemical API CDMO Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Chemical API CDMO Market Size (2021-2032)
- 10.2 Asia Chemical API CDMO Market Size by Type
- 10.2.1 Asia Chemical API CDMO Market Size by Type (2021-2026)
- 10.2.2 Asia Chemical API CDMO Market Size by Type (2027-2032)
- 10.2.3 Asia Chemical API CDMO Market Share by Type (2021-2032)
- 10.3 Asia Chemical API CDMO Market Size by Application
- 10.3.1 Asia Chemical API CDMO Market Size by Application (2021-2026)
- 10.3.2 Asia Chemical API CDMO Market Size by Application (2027-2032)
- 10.3.3 Asia Chemical API CDMO Market Share by Application (2021-2032)
- 10.4 Asia Chemical API CDMO Market Size by Country
- 10.4.1 Asia Chemical API CDMO Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Chemical API CDMO Market Size by Country (2021-2026)
- 10.4.3 Asia Chemical API CDMO Market Size by Country (2027-2032)
- 10.4.4 Asia Chemical API CDMO Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Chemical API CDMO Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Chemical API CDMO Market Size by Type
- 11.2.1 South America, Middle East & Africa Chemical API CDMO Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Chemical API CDMO Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Chemical API CDMO Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Chemical API CDMO Market Size by Application
- 11.3.1 South America, Middle East & Africa Chemical API CDMO Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Chemical API CDMO Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Chemical API CDMO Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Chemical API CDMO Market Size by Country
- 11.4.1 South America, Middle East & Africa Chemical API CDMO Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Chemical API CDMO Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Chemical API CDMO Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Chemical API CDMO Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst